Antitumor effects of inductive hyperthermia using magnetic ferucarbotran nanoparticles on human lung cancer xenografts in nude mice

OncoTargets and Therapy

Volumn 6, Issue , 2013, Pages 237-242

  Araya, Tomoyuki ^a   Kasahara, Kazuo ^a   Nishikawa, Shingo ^a   Kimura, Hideharu ^a   Sone, Takashi ^a   Nagae, Hideo ^a   Ikehata, Yoshio ^a   Nagano, Isamu ^a   Fujimura, Masaki ^a  

^a KANAZAWA UNIVERSITY   (Japan)

Author keywords

Alternating magnetic field; Ferucarbotran; Human use; Inductive hyperthermia; Lung cancer; Magnetic nanoparticles

Indexed keywords

FERUCARBOTRAN; MAGNETIC NANOPARTICLE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY TEMPERATURE MEASUREMENT; CANCER INHIBITION; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HYPERTHERMIC THERAPY; LUNG CANCER; MAGNETIC FIELD; MOUSE; NONHUMAN; RISK ASSESSMENT; THERAPY EFFECT; TUMOR VOLUME; TUMOR XENOGRAFT; WEIGHT REDUCTION;

EID: 84875412321     PISSN: 11786930     EISSN: None     Source Type: Journal    
DOI: 10.2147/OTT.S42815     Document Type: Article

References (31)

1. Baba H, Stephens LC, Strebel FR, et al. Protective effect of ICRF-187 against normal tissue injury induced by adriamycin in combination with whole body hyperthermia. Cancer Res. 1991;51(13):3568-3577.
2. Ikeda N, Hayashida O, Kameda H, Ito H, Matsuda T. Experimental study on thermal damage to dog normal brain. Int J Hyperthermia. 1994;10(4):553-561.
3. Lin JC, Wang YJ. Interstitial microwave antennas for thermal therapy. Int J Hyperthermia. 1987;3(1):37-47.
4. Stauffer PR, Cetas TC, Fletcher AM, et al. Observations on the use of ferromagnetic implants for inducing hyperthermia. IEEE Trans Biomed Eng. 1984;31(1):76-90.
5. DeNardo SJ, DeNardo GL, Miers LA, et al. Development of tumor targeting bioprobes (111)In-chimeric L6monoclonal antibody nanoparticles) for alternating magnetic field cancer therapy. Clin Cancer Res. 2005;11(19):7087s-7092s.
6. Jordan A, Wust P, Fähling H, John W, Hinz A, Felix R. Inductive heating of ferrimagnetic particles and magnetic fluids: physical evaluation of their potential for hyperthermia. Int J Hyperthermia. 1993;9(1): 51-68.
7. Fannin PC. Magnetic spectroscopy as an aide in understanding magnetic fluids. J Magn Magn Mater. 2002;252:59-64.
8. Ma M, Wu Y, Zhou J, Sun Y, Zhang Y, Gu N. Size dependence of specific power absorption of Fe3O4 particles in AC magnetic field. J Magn Magn Mater. 2004;268:33-39.
9. Shinkai M, Yanase M, Honda H, Wakabayashi T, Yoshida J, Kobayashi T. Intracellular hyperthermia for cancer using magnetite cationic liposomes: in vitro study. Jpn J Cancer Res. 1996;87(11):1179-1183.
10. Mitsumori M, Hiraoka M, Shibata T, et al. Targeted hyperthermia using dextran magnetite complex: a new treatment modality for liver tumors. Hepatogastroenterology. 1996;43(12):1431-1437.
11. Hilger I, Fruhauf K, Andra W, Hiergeist R, Hergt R, Kaiser WA. Heating potential of iron oxides for therapeutic purposes in interventional radiology. Acad Radiol. 2002;9(2):198-202.
12. Mitsumori M, Hiraoka M, Shibata T, et al. Development of intra-arterial hyperthermia using a dextran-magnetite complex. Int J Hyperthermia. 1994;10(6):785-793.
13. Takamatsu S, Matsui O, Gabata T, et al. Selective induction hyperthermia following transcatheter arterial embolization with a mixture of nano-sized magnetic particles (ferucarbotran) and embolic materials: feasibility study in rabbits. Radiat Med. 2008;26(4):179-187.
14. Yamada K, Oda T, Hashimoto S, et al. Minimally required heat doses for various tumour sizes in induction heating cancer therapy determined by computer simulation using experimental data. Int J Hyperthermia. 2010;26(5):465-474.
15. Murase K, Oonoki J, Takata H, et al. Simulation and experimental studies on magnetic hyperthermia with use of superparamagnetic iron oxide nanoparticles. Radiol Phys Technol. 2011;4(2):194-202.
16. Johannsen M, Gneveckow U, Eckelt L, et al. Clinical hyperthermia of prostate cancer using magnetic nanoparticles: presentation of a new interstitial technique. Int J Hyperthermia. 2005;21(7):637-647.
17. Ito A, Tanaka K, Honda H, Abe S, Yamaguchi H, Kobayashi T. Complete regression of mouse mammary carcinoma with a size greater than 15mm by frequent repeated hyperthermia using magnetite nanoparticles. J Biosci Bioeng. 2003;96(4):364-369.
18. Reimer P, Balzer T. Ferucarbotran (Resovist): a new clinically approved RES-specific contrast agent for contrast-enhanced MRI of the liver: properties, clinical development, and applications. Eur Radiol. 2003;13(6):1266-1276.
19. Hamm B, Staks T, Taupitz M, et al. Contrast-enhanced MR imaging of liver and spleen: first experience in humans with a new superparamagnetic iron oxide. J Magn Reson Imaging. 1994;4(5):659-668.
20. Hirohashi S, Ichikawa T, Tanimoto A, et al. Dose investigation of superparamagnetic iron oxide (SPIO) SH U 555A in liver MR imaging. Nippon Igaku Hoshasen Gakkai Zasshi. 2003;63(9):539-550. Japanese.
21. Ciardiello F, Bianco R, Damiano V, et al. Antitumor activity of sequential treatment with topotecan and antiepidermal growth factor receptor monoclonal antibody C225. Clin Cancer Res. 1999;5(4):909-916.
22. International Commission on Non-Ionizing Radiation Protection. Guidelines for limiting exposure to time-varying electric, magnetic, and electromagnetic fields (up to 300 GHz); ICNIRP guidelines. Health Phys. 1998;74:494-522.
23. Dewey WC, Hopwood LE, Sapareto SA, Gerweck LE. Cellular responses to combinations of hyperthermia and radiation. Radiology. 1977;123(2):463-474.
24. Magistrelli P, Coppola R, Tonini G, et al. Apoptotic index or a combination of Bax/Bcl-2 expression correlate with survival after resection of pancreatic adenocarcinoma. J Cell Biochem. 2006;97(1):98-108.
25. Ito A, Honda K, Kobayashi T. Cancer immunotherapy based on intracellular hyperthermia using magnetite nanoparticles: a novel concept of "heat-controlled necrosis" with heat shock protein expression. Cancer Immunol Immunother. 2006;55(3):320-328.
26. Yonezawa M, Otsuka T, Matsui N, et al. Hyperthermia induces apoptosis in malignant fibrous histiocytoma cells in vitro. Int J Cancer. 1996;66(3):347-351.
27. Wang L, Dong J, Ouyang W, Wang X, Tang J. Anticancer effect and feasibility study of hyperthermia treatment of pancreatic cancer using magnetic nanoparticles. Oncol Rep. 2012;27(3):719-726.
28. Hu R, Ma S, Li H, et al. Effect of magnetic fluid hyperthermia on lung cancer nodules in a murine model. Oncol Lett. 2011;2(6):1161-1164.
29. Hu R, Zhang X, Liu X, et al. Higher temperature improves the efficacy of magnetic fluid hyperthermia for Lewis lung cancer in a mouse model. Thorac Cancer. 2012;3:34-39.
30. Jiang Z, Yan W, Ming J, et al. Docetaxel weekly regimen in conjunction with RF hyperthermia for pretreated locally advanced non-small cell lung cancer: a preliminary study. BMC Cancer. 2007;7:189.
31. Hei TK, Hall EJ, Kushner S, Osmak RS. Hyperthermia, chemotherapeutic agents and oncogenic transformation. Int J Hyperthermia. 1986;2(3):311-320.